Results 1 to 10 of about 749,719 (265)

RSV vaccine development: advances and fusion protein-focused strategies. [PDF]

Front Immunol
Xu W, Katte RH, Lu M.
europepmc   +1 more source

Impact of Neonatal Fc Receptor on Transferrin Receptor Antibody Fusion Protein Pharmacokinetics. [PDF]

Pharmaceutics
Oyegbesan A, Jagadeesan N, Chandrashekar DV, Sumbria RK.   +3 more
europepmc   +1 more source

Repurposing antiviral drugs targeting RNA viruses: A focus on the fusion protein of human metapneumovirus. [PDF]

North Clin Istanb
Aras M, Yayintas OT.
europepmc   +1 more source

A barrier-crossing and immune checkpoint-blocking antibody fusion protein for enhanced glioma-targeted immunotherapy. [PDF]

Asian J Pharm Sci
Bao Y, Yang S, Ding Y, Zhou J, Zheng X, Chen R, Jiang Z, Meng N, Pan D, Lu J, Guan J, Ye J, Zhu H, Xu N, Xie C, Yu L, Lu L, Lu W.   +17 more
europepmc   +1 more source

FusionTarget: Computational framework for drug repurposing against modeled fusion protein structures from genomic breakpoints. [PDF]

iScience
Kumar H, Tsang SV, Lee MS, Huang YH, Choi J, Lotlikar SR, Song JY, Toh A, Choi YL, Brannan KW, Kim P.   +10 more
europepmc   +1 more source

One-step cleavage and purification: a bifunctional IdeS-Protein A fusion protein for on-column generation of antibody fragments. [PDF]

MAbs
Zhang T, Liao H, Teng CB, Wang C.
europepmc   +1 more source

A Biomimetic Amelogenin-Fibronectin Fusion Protein with Dual Cell-Adhesive and Osteoinductive Functions for Alveolar Bone Defect Repair. [PDF]

Bioengineering (Basel)
Zheng M, Jiang X, Lei M, Liang B, Ye X, Xie L, Zhang P, Li Y, Hong A, Su Z, Chen X.   +10 more
europepmc   +1 more source

A fusion protein's weak link: functional constraints revealed by inhibitory peptide interaction with the parainfluenza fusion protein. [PDF]

mBio
Crosby M, Kuhn AJ, Zipursky G, Marcink TC, Stearns K, Sobolik EB, Vyshenska D, Mook JC, Greninger AL, Porotto M, Gellman SH, Moscona A.   +11 more
europepmc   +1 more source

Streptococcus-derived CpsA-CpsC fusion protein induces apoptosis in cervical cancer cells through in silico and in vitro methods. [PDF]

Sci Rep
Marzhoseyni Z, Shayestehpour M, Shaghaghi Z, Alvandi M, Esmaeili D.   +4 more
europepmc   +1 more source

Epitope-based vaccine of NiV targeting glycoprotein and fusion protein: an integrated immunoinformatics and bioinformatics approach. [PDF]

Virus Res
Aggad WS, Mishra SK, Alqahtani T, Guendouzi A, Tóth Z, Zaki MEA.   +5 more
europepmc   +1 more source